(Reuters) - An analysis of 26 clinical trials found no higher risk of heart attacks with AIDS drug abacavir compared with other HIV medicines, U.S. health officials said on Tuesday. The Food and Drug Administration reviewed data on abacavir after studies showed conflicting information about a possible link to heart attacks.
